SCHEMBL22005296

SCHEMBL22005296

CCCCCCCC(CCCCCCC)OC(N)=O

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 7/20 0.45
FFAR1 O14842 1/20 0.45
MAPT P10636 2/20 0.44
ZDHHC7 Q9NXF8 1/20 0.44
MAPK1 P28482 1/20 0.44
LCK P06239 1/20 0.44
PPARD Q03181 1/20 0.44
ZDHHC20 Q5W0Z9 1/20 0.44
ZDHHC2 Q9UIJ5 1/20 0.44
LMNA P02545 3/20 0.42
LAP3 P28838 1/20 0.42
CA2 P00918 1/20 0.42
FAAH O00519 1/20 0.42
GRIK1 P39086 1/20 0.42
GRIK2 Q13002 1/20 0.42
ALDH1A1 P00352 1/20 0.42
SMPD1 P17405 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2436142 1.00 GPR84 (0.45) GPR84FFAR1MAPTZDHHC7MAPK1
SCHEMBL27891806 1.00 GPR84 (0.45) GPR84FFAR1MAPTZDHHC7MAPK1
SCHEMBL20459198 1.00 GPR84 (0.45) GPR84FFAR1MAPTZDHHC7MAPK1
SCHEMBL5013944 1.00 GPR84 (0.45) GPR84FFAR1MAPTZDHHC7MAPK1
SCHEMBL21300541 1.00 GPR84 (0.45) GPR84FFAR1MAPTZDHHC7MAPK1
SCHEMBL5012509 1.00 GPR84 (0.45) GPR84FFAR1MAPTZDHHC7MAPK1
SCHEMBL5953699 0.98 CA2 (0.46) GPR84FFAR1MAPTZDHHC7MAPK1
SCHEMBL4856594 0.98 CA2 (0.46) GPR84FFAR1MAPTZDHHC7MAPK1
SCHEMBL10844707 0.98 GPR84 (0.42) GPR84FFAR1MAPTZDHHC7MAPK1
SCHEMBL20835181 0.96 CTSK (0.42) GPR84FFAR1MAPTZDHHC7MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200157053-A1 Method of Treating or Inhibiting Malaria UNIV OREGON HEALTH & SCIENCE (US) 2020-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200157053-A1 Method of Treating or Inhibiting Malaria ELANE, ELF3, ELOB GPR84 3859/4885FFAR1 3606/4885MAPT 2980/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.